Plutus Investment Group
Overview
Plutus Investment Group is a family office that focuses on backing startups in Europe and the USA. They look for leaders with a drive and a strong vision and provide the time, energy and capital for those companies to succeed and become game changers .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oxford Cancer Biomarkers | Apr 2023 | VC Round | Lead |
| BoltOS | Dec 2022 | Seed | Co-investor |
| MPC Therapeutics AG | Jan 2023 | Seed | Lead |
| Bolt Group | Dec 2022 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Nadir Gmira
Venture Partner
Pete Petrov
Venture Partner
Zakariya Kmir
Venture Partner
Tim Y. Chen
Investment Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Plutus Investment Group based?
Plutus Investment Group is headquartered in London, England, United Kingdom.
When was Plutus Investment Group founded?
Plutus Investment Group was founded in 2021.
How many portfolio companies does Plutus Investment Group have?
Plutus Investment Group has 5 portfolio companies in Caplight's dataset.
What are some companies in Plutus Investment Group's portfolio?
Portfolio companies visible on Caplight include Oxford Cancer Biomarkers, BoltOS, MPC Therapeutics AG, Bolt Group.
What was Plutus Investment Group's most recent investment shown here?
Plutus Investment Group's most recent investment in this portfolio sample was in Oxford Cancer Biomarkers in 2023.
What sectors does Plutus Investment Group focus on?
Plutus Investment Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Media, Entertainment & Gaming, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does Plutus Investment Group focus on?
Plutus Investment Group typically invests at the Early stage.
What is Plutus Investment Group's AUM?
Plutus Investment Group's assets under management are estimated between $50.0M and $100.0M.